Columnist Connie Chandler may have limited control over her physical abilities, but she can always strengthen her faith and ...

Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...

Discover the most-read SMA stories of 2025, featuring updates on the gene therapy Zolgensma, next-generation treatments, and ...

Columnist Connie Chandler offers a message of courage and hope for those spending this season in a hospital bed.

This Christmas, columnist Ari Anderson gives thanks that some health complications he experienced post-surgery resolved on ...

Columnist Brianna Albers is not good at waiting. One might say she's terrible at it. Living with SMA, though, seems to bring a lot of it.

A new review of studies reveals that incorporating SMA into newborn screening programs yields clinical improvements and reduces costs.

Diaphragm fatigue contributes to breathing difficulties in patients with SMA. Other respiratory muscles did not exhibit similar signs of fatigue. These findings could guide new therapeutic strategies ...

Our daughter, Charlie-Anne, was born on June 22, 2009. When the doctor handed her to me, I was shocked to see a full head of beautiful, red hair. I was instantly in love. I had been diagnosed with ...

Zolgensma improved motor function in SMA children with tracheostomies. No new safety risks were observed for SMA patients with tracheostomy who received Zolgensma. Many patients received Spinraza or ...

FDA approved Itvisma, a one-time gene therapy for SMA patients ages 2 and older. Itvisma restores SMN protein, improving motor function and reducing treatment burden. A Novartis executive says the ...